EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

A focus on dominant negative variants in a series of 170 heterozygous FXI‐deficient patients

Philippe de Mazancourt iD, Florence Quélin, Claire Flaujac, Emmanuelle de Raucourt iD, Benoît Guillet iD, Frédéric Bauduer, Vincent Ernest, Philippe Beurrier, Aurélie Avril, Roseline d'Oiron iD, Christine Biron-Andréani iD, Sandrine Meunier and 1 more

Haemophilia · 2023

DOI: 10.1111/hae.14802 ↗

At a glance

Journal article in Haemophilia, 2023. Written by Philippe de Mazancourt and 12 co-authors. Institution: UMR1179, Université de Versailles-Saint-Quentin, Montigny le Bretonneux, France. Major MEDLINE topics: Factor XI, Factor XI Deficiency. Cited 2 times so far (Crossref); 20 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: University of Versailles-St-Quentin, Assistance Publique-Hôpitaux de Paris.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Dominant‐negative effects have been described for 10 F11 variants in the literature.

Aim

The current study aimed at identifying putative dominant‐negative F11 variants. Material and methods This research consisted in a retrospective analysis of routine laboratory data.

Results

In a series of 170 patients with moderate/mild factor XI (FXI) deficiencies, we identified heterozygous carriers of previously reported dominant‐negative variants (p.Ser243Phe, p.Cys416Tyr, and p.Gly418Val) with FXI activities inconsistent with a dominant‐negative effect. Our findings also do not support a dominant‐negative effect of p.Gly418Ala. We also identified a set of patients carrying heterozygous variants, among which five out of 11 are novel, with FXI activities suggesting a dominant‐negative effect (p.His53Tyr, p.Cys110Gly, p.Cys140Tyr, p.Glu245Lys, p.Trp246Cys, p.Glu315Lys, p.Ile421Thr, p.Trp425Cys, p.Glu565Lys, p.Thr593Met, and p.Trp617Ter). However, for all but two of these variants, individuals with close to half normal FXI coagulant activity (FXI:C) were identified, indicating an inconstant dominant effect.

Conclusion

Our data show that for some F11 variants recognized has having dominant‐negative effects, such effects actually do not occur in many individuals. The present data suggest that for these patients, the intracellular quality control mechanisms eliminate the variant monomeric polypeptide before homodimer assembly, thereby allowing only the wild‐type homodimer to assemble and resulting in half normal activities. In contrast, in patients with markedly decreased activities, some mutant polypeptides might escape this first quality control. In turn, assembly of heterodimeric molecules as well as mutant homodimers would result in activities closer to 1:4 of FXI:C normal range.

Subjects

MeSH terms (MEDLINE)

Factor XIFactor XI DeficiencyHumansRetrospective StudiesHeterozygotePedigree

Author keywords

F11 geneF11 variantFXI deficiencyHPO 0001928 Abnormality of coagulationHPO 0003256 Abnormality of the coagulation cascadedominant negative variant

Substances

Factor XI

Authors and institutions

  • UMR1179, Université de Versailles-Saint-Quentin, Montigny le Bretonneux, France.
  • Laboratoire de Biologie Moléculaire, Hôpital A. Paré, APHP.Paris-Saclay, Boulogne-Billancourt, France.
  • Département de Recherche Clinique, CH Versailles, Le Chesnay, France.
  • Laboratoire de biologie médicale, secteur hémostase, centre hospitalier de Versailles (André Mignot), Le Chesnay, France.
  • Centre de Ressources et de Compétences Maladies Hémorragiques Constitutionnelles, CH de Versailles, Le Chesnay, France.
  • Centre de Traitement des maladies hémorragiques, Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France.

ORCID profiles: Philippe de Mazancourt, Emmanuelle de Raucourt, Benoît Guillet, Roseline d'Oiron, Christine Biron-Andréani

Funding

  • University of Versailles-St-Quentin
  • Assistance Publique-Hôpitaux de Paris

Cite

APA

de Mazancourt, P., Quélin, F., Flaujac, C., de Raucourt, E., Guillet, B., Bauduer, F., Ernest, V., Beurrier, P., Avril, A., d'Oiron, R., Biron-Andréani, C., Meunier, S., & Dargaud, Y. (2023). A focus on dominant negative variants in a series of 170 heterozygous FXI‐deficient patients. Haemophilia. https://doi.org/10.1111/hae.14802

Vancouver

de Mazancourt P, Quélin F, Flaujac C, de Raucourt E, Guillet B, Bauduer F, et al. A focus on dominant negative variants in a series of 170 heterozygous FXI‐deficient patients. Haemophilia. 2023. doi:10.1111/hae.14802

BibTeX
@article{deMazancourt2023,
  author = {de Mazancourt, Philippe and Quélin, Florence and Flaujac, Claire and de Raucourt, Emmanuelle and Guillet, Benoît and Bauduer, Frédéric and Ernest, Vincent and Beurrier, Philippe and Avril, Aurélie and d'Oiron, Roseline and Biron-Andréani, Christine and Meunier, Sandrine and Dargaud, Yesim},
  title = {A focus on dominant negative variants in a series of 170 heterozygous FXI‐deficient patients},
  journal = {Haemophilia},
  year = {2023},
  doi = {10.1111/hae.14802}
}
Start for free →